180 Life Sciences Corp. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
180 Life Sciences Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q4 2016 to Q3 2024.
  • 180 Life Sciences Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 981K shares, a 134% increase year-over-year.
  • 180 Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 379K shares, a 279% increase from 2022.
  • 180 Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 100K shares, a 93.6% decline from 2021.
  • 180 Life Sciences Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.57M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 981K +562K +134% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 919K +644K +234% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 638K +441K +224% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 379K +279K +279% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 419K -1.54M -78.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 275K -1.43M -83.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 197K -1.51M -88.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 100K -1.47M -93.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 1.96M -30.8M -94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.71M -29.8M -94.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 1.7M -26.3M -93.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 1.57M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 32.7M +15.9M +94.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 31.5M +14.6M +86.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 28M +23.5M +527% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 16.9M +12.6M +295% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 16.9M +12.6M +299% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 4.46M +358K +8.73% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-22
Q4 2019 4.22M +53.8K +1.29% Oct 1, 2019 Dec 31, 2019 10-K 2020-04-07
Q3 2019 4.26M +90.5K +2.17% Jul 1, 2019 Sep 30, 2019 10-Q/A 2021-02-05
Q2 2019 4.23M +43.2K +1.03% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-02-05
Q1 2019 4.1M -101K -2.41% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 4.17M +720K +20.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-07
Q3 2018 4.17M -42.8K -1.02% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 4.18M +1.33M +46.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 4.2M +1.7M +68.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 3.45M +950K +38% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 4.22M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 2.85M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 2.5M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 2.5M Sep 7, 2016 Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.